Stock Traders Buy Large Volume of Put Options on VanEck Pharmaceutical ETF (NASDAQ:PPH)

VanEck Pharmaceutical ETF (NASDAQ:PPH) was the recipient of some unusual options trading on Thursday. Stock traders purchased 7,698 put options on the stock. This is an increase of approximately 2,233% compared to the typical daily volume of 330 put options.

VanEck Pharmaceutical ETF Stock Performance

NASDAQ:PPH opened at $83.98 on Friday. The stock has a 50-day simple moving average of $89.29 and a 200 day simple moving average of $89.39. VanEck Pharmaceutical ETF has a 52-week low of $77.67 and a 52-week high of $99.51. The company has a market cap of $582.82 million, a PE ratio of 24.31 and a beta of 0.72.

VanEck Pharmaceutical ETF Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 4th. Stockholders of record on Tuesday, April 1st were given a $0.5245 dividend. This represents a $2.10 dividend on an annualized basis and a dividend yield of 2.50%. The ex-dividend date of this dividend was Tuesday, April 1st. This is a positive change from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.31.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in PPH. SBI Securities Co. Ltd. acquired a new position in shares of VanEck Pharmaceutical ETF during the 4th quarter worth about $29,000. Activest Wealth Management acquired a new position in shares of VanEck Pharmaceutical ETF during the 4th quarter worth approximately $32,000. Park Square Financial Group LLC acquired a new stake in shares of VanEck Pharmaceutical ETF in the 4th quarter valued at approximately $43,000. Farther Finance Advisors LLC grew its stake in shares of VanEck Pharmaceutical ETF by 391.0% in the first quarter. Farther Finance Advisors LLC now owns 545 shares of the company’s stock valued at $48,000 after buying an additional 434 shares in the last quarter. Finally, Tidemark LLC increased its holdings in VanEck Pharmaceutical ETF by 123.6% during the fourth quarter. Tidemark LLC now owns 1,183 shares of the company’s stock worth $102,000 after buying an additional 654 shares during the last quarter.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.